Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators

Nanotoxicology

Volumn 5, Issue 3, 2011, Pages 284-295

  Zhang, Qin ^a   Hitchins, Victoria M ^a   Schrand, Amanda M ^b   Hussain, Saber M ^b   Goering, Peter L ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b WRIGHT PATTERSON AIR FORCE BASE   (United States)

Author keywords

Cytokine; Cytotoxicity; Gold nanoparticles; Inflammation; Macrophages

Indexed keywords

GOLD NANOPARTICLE; HYDROGEN PEROXIDE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL VACUOLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENZYME ACTIVITY; FOOD SAFETY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CELL SURVIVAL; GOLD; MACROPHAGES; METAL NANOPARTICLES; MICE;

MURINAE;

EID: 80052058658     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2010.512401     Document Type: Article

References (39)

1. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 2008. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608-13619.
2. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S. 2007. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050-2055. (Pubitemid 46391350)
3. Chanda N, Shukla R, Katti KV, Kannan R. 2009. Gastrin releasing protein receptor specific gold nanorods: Breast and prostate tumor avid nanovectors for molecular imaging. Nano Lett 9:1798-1805.
4. Chithrani BD, Chan WC. 2007. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542-1550. (Pubitemid 47140422)
5. Chithrani BD, Stewart J, Allen C, Jaffray DA. 2009. Intracellular uptake, transport, and processing of nanostructures in cancer cells. Nanomedicine 5:118-127.
6. Choi J, Zhang Q, Reipa V, Wang NS, Stratmeyer ME, Hitchins VM, Goering PL. 2009. Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J Appl Toxicol 29:52-60.
7. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325-327. (Pubitemid 43951781)
8. Daniel MC, Astruc D. 2004. Gold nanoparticles: Assembly, supra-molecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104:293-346.
9. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Bioma-terials 29:1912-1919.
10. Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. 2008. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180-2187.
11. Dobrovolskaia MA, Germolec DR, Weaver JL. 2009. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 4:411-414.
12. El-Sayed IH, Huang X, El-Sayed MA. 2005. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer. Nano Lett 5:829-834. (Pubitemid 40749040)
13. Goering PL, Kuester RK, Neale AR, Chapekar MS, Zaremba TG, Gordon EA, Hitchins VM. 2000. Effects of particulate and soluble cadmium species on biochemical and functional parameters in cultured murine macrophages. In Vitro Mol Toxicol 13:125-136. (Pubitemid 32937621)
14. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconj Chem 15:897-900. (Pubitemid 38981966)
15. Han G, Ghosh P, Rotello VM. 2007. Functionalized gold nano-particles for drug delivery. Nanomedicine 2:113-123. (Pubitemid 46845782)
16. Huang X,Jain PK, El-Sayed IH, El-Sayed MA. 2007. Gold nanopar-ticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2:681-693. (Pubitemid 350268247)
17. Jin H, Heller DA, Sharma R, Strano MS. 2009. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: Single particle tracking and a generic uptake model for nano-particles. ACS Nano 3:149-158.
18. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2009. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur J Pharm Biopharm 72:370-377.
19. Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, Lacroix G, Hoet P. 2009. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol 6:14.
20. Lipscomb MF. 1989. Lung defenses against opportunistic infections. Chest 96:1393-1399. (Pubitemid 20000843)
21. Lyle DB, Shallcross JC, Durfor CN, Hitchins VM, Breger JC, Langone JJ. 2009. Screening biomaterials for stimulation of nitric oxide-mediated inflammation. J Biomed Mater Res A 90:82-93.
22. Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222-235.
23. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239-253.
24. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2:8.
25. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W. 2007. Size-dependent cytotox-icity of gold nanoparticles. Small 3:1941-1949.
26. Parab HJ, Chen HM, Lai TC, Huang JH, Chen PH, Liu RS, Hsiao M, Chen CH, Tsai DP, Hwu YK. 2009. Biosensing, cytotoxicity, and cellular uptake studies of surface-modified gold nanorods. J Phys Chem C 113:7574-7578.
27. Pulskamp K, Diabate S, Krug HF. 2007. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168: 58-74. (Pubitemid 44909723)
28. Schrand AM, Braydich-Stolle LK, Schlager JJ, Dai LM, Hussain SM. 2008. Can silver nanoparticles be useful as potential biological labels? Nanotechnology 19:104-117.
29. Schrand AM, Huang H, Carlson C, Schlager JJ, Omacr SE, Hussain SM, Dai L. 2007. Are diamond nanoparticles cytotoxic? J Phys Chem B 111:2-7. (Pubitemid 46277964)
30. Schrand AM, Schlager JJ, Dai L, Hussain SM. 2010. Preparing cells dosed with nanomaterials for assessment of internalization and localization with transmission electron microscopy. Nature Protocols 5:744-757.
31. Sharma P, Brown SC, Bengtsson N, Zhang Q, Walter GA, Grobmyer SR, Santra S, Jiang H, Scott EW, Moudgil BM. 2008. Gold-speckled multimodal nanoparticles for noninvasive bioimaging. Chem Mater 20:6087-6094.
32. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. 2005. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21:10644-10654. (Pubitemid 41692144)
33. Storhoff JJ, Mirkin CA. 1999. Programmed materials synthesis with DNA. Chem Rev 99:1849-1862. (Pubitemid 129585163)
34. Tantra R, Tompkins J, Quincey P. 2010. Characterisation of the de-agglomeration effects of bovine serum albumin on nanopar-ticles in aqueous suspension. Colloids Surf B Biointerfaces 75:275-281.
35. Thaxton CS, Rosi NL, Mirkin CA. 2005. Optically and chemically encoded nanoparticle materials for DNA and protein detection. MRS Bull 30:376-380. (Pubitemid 43827715)
36. Voskerician G, Shive MS, Shawgo RS, von Recum H, Anderson JM, Cima MJ, Langer R. 2003. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 24:1959-1967. (Pubitemid 36297040)
37. Wang SG, Lu WT, Tovmachenko O, Rai US, Yu HT, Ray PC. 2008. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin kerati-nocytes. Chem Phys Lett 463:145-149.
38. Yen HJ, Hsu SH, Tsai CL. 2009. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5:1553-1561.
39. Yi H, Leunissen JLM, Shi GM, Gutekunst CA, Hersch SM. 2001. A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural level. J Histochem Cytochem 49:279-283. (Pubitemid 32176389)